Abstract
This study was devised to identify potential biomarkers of schizophrenia (SP) using proteomics techniques. We obtained 44 serum specimens from patients with SP, 26 specimens from patients with depression, and 40 specimens from healthy controls. Immobilized metal affinity capture protein chips (IMAC30) and surface-enhanced laser desorption-ionization time-of-flight mass spectrometry were used to isolate and obtain mass spectrometric data of differentially expressed serum proteins. The sequences of the peaks discrepant among the study groups were obtained using matrix-assisted laser desorption/ionization mass spectrometry and proteins identified using Mascot database. In the SP group, there were 91 protein peaks that were different from other study groups at the p value of <0.05 and 54 peaks different at the p value of <0.01. Two protein peaks at the mass-to-charge ratio of 1,207.41 and 1,466.78 were markedly different among the study groups, with the lowest expression in specimens from patients with SP. The amino acid sequences were, respectively, Glu-Gly-Asp-Phe-Leu-Ala-Glu-Gly-Gly-Gly-Val-Arg (EGDFLAEGGGVR) and Asp-Ser-Gly-Glu-Gly-Asp-Phe-Leu-Ala-Glu-Gly-Gly-Gly-Val-Arg (DSGEGDFLAEGGGVR). These proteins were identified as the N-terminal fragments of fibrinogen. In conclusion, these biomarker proteins may be useful for molecular diagnosis of SP.
Similar content being viewed by others
Abbreviations
- SELDI-TOF–MS:
-
Surface-enhanced laser desorption/ionization, time-of-flight mass spectrometry
- SPA:
-
Sinapinic acid
- MALDI-TOF–MS:
-
Matrix assisted laser desorption/ionization, mass spectrometry
- CV:
-
Coefficient of variance
- m/z :
-
Mass-to-charge ratio
- IMAC30:
-
Immobilized metal affinity surface
- TFA:
-
Trifluoroacetic acid
- EAM:
-
Energy absorption molecules
References
van Os, J., Rutten, B. P., & Poulton, R. (2008). Gene-environment interactions in schizophrenia: Review of epidemiological findings and future directions. Schizophrenia Bulletin, 34, 1066–1082.
Lakhan, S. E. (2006). Schizophrenia proteomics: Biomarkers on the path to laboratory medicine? Diagnostic Pathology, 2006(1), 11.
Zhai, J., Xu, S. Z., & Cui, J. J. (2008). Investigation of clinical value S100B plasma levels in patients with schizophrenia. Journal of Psychiatry, 21, 261–262. in Chinese.
Boyer, L., Murcia, A., Belzeaux, R., Loundou, A., Azorin, J. M., Chabannes, J. M., et al. (2010). Psychometric properties of the Activities Daily Life Scale (ADL). L’Encephale, 36, 408–416. in French.
Sun Xue, L. (2008). Psychiatry. Beijing: Higher Education Press. in Chinese.
Ding, Y. H., Hu, Q. Y., & Liang, S. H. (2009). Using an internal standard calibration method to improve detection repeatability of surface-enhanced laser desorption ionization time-of-flight mass spectrometry. Chinese Journal of Laboratory Medicine, 32, 337–339. in Chinese.
Diamandis, E. P. (2003). Point: Proteomic patterns in biological fluids: Do they represent the future of cancer diagnostics? Clinical Chemistry, 2003(49), 1272–1275.
Jiang, W., & Wang, K. Z. (2006). Application and progress of protein chip technique on clinical research. Laboratory Medicine and Clinical, 2006(3), 308–310(in Chinese).
Lin, Y. W., Lin, C. Y., Lai, H. C., Chiou, J. Y., Chang, C. C., Yu, M. H., & Chu, T. Y. (2006). Plasma proteomic pattern as biomarkers for ovarian cancer. International Journal of Gynecological Cancer, 16(Suppl 1), 139–146.
Ding, Y. H., & Wang, K. Z. (2008). Statistical evaluation of SELDI-TOF-MS in early diagnosis of breast cancer. Letters in Biotechnology, 2008(19), 708–710.
Pham, T. D. (2008). Computational prediction models for cancer classification using mass spectrometry data. International Journal of Data Mining and Bioinformatics, 2008(2), 405–422.
Mei, J., Kolbin, D., Kao, H. T., & Porton, B. (2006). Protein expression profiling of postmortem brain in schizophrenia. Schizophrenia Research, 84, 204–213.
Jiang, W., Wang, K. Z., & Bai, K. Z. (2008). The study on clinical application of serum proteins as biological markers of schizophrenia. Chinese Journal of Nervous and Mental Disease, 34, 27–30. in Chinese.
Craddock, R. M., Huang, J. T., Jackson, E., Harris, N., Torrey, E. F., Herberth, M., & Bahn, S. (2008). Increased alpha-defensins as a blood marker for schizophrenia susceptibility. Molecular and Cellular Proteomics, 7, 1204–1213.
Sfanos, K. S., Wilson, B. A., De Marzo, A. M., & Isaacs, W. B. (2009). Acute inflammatory proteins constitute the organic matrix of prostatic corpora amylacea and calculi in men with prostate cancer. Proceedings of the National Academy of Sciences of the United States of America, 106, 3443–3448.
Ramasundara, M., Leach, S. T., Lemberg, D. A., & Day, A. S. (2009). Defensins and inflammation: The role of defensins in inflammatory bowel disease. Journal of Gastroenterology and Hepatology, 24, 202–208.
Venkataraman, N., Cole, A. L., Ruchala, P., Waring, A. J., Lehrer, R. I., Stuchlik, O., et al. (2009). Reawakening retrocyclins: Ancestral human defensins active against HIV-1. PLoS Biology, 7, e95.
Herrero, A. M., Cambero, M. I., Ordonez, J. A., Castejon, D., Romero de Avila, M. D., & de la Hoz, L. (2007). Magnetic resonance imaging, rheological properties, and physicochemical characteristics of meat systems with fibrinogen and thrombin. Journal of Agriculture and Food Chemistry, 55, 9357–9364.
Acknowledgments
The authors wish to thank the National High Technology Research and Development Program (Program 863, Grant Number 2006AA02090407) for providing funding for the study.
Conflict of interest
The authors declare no competing interests.
Author information
Authors and Affiliations
Corresponding author
Additional information
Yin-huan Ding and Jian-hong Guo contributed equally to this study and should be considered co-first authors.
Rights and permissions
About this article
Cite this article
Ding, Yh., Guo, Jh., Hu, Qy. et al. Protein Biomarkers in Serum of Patients with Schizophrenia. Cell Biochem Biophys 72, 799–805 (2015). https://doi.org/10.1007/s12013-015-0536-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12013-015-0536-5